A randomized trial of homeopathic medicines for heavy menstrual bleeding in reproductive females

Published: 15 October 2026| Version 1 | DOI: 10.17632/s47kmxmsm5.1
Contributors:
,
,
,
,
,
,
,
,
,
,
,
,
,
,

Description

Evidence regarding individualized homeopathic medicines (IHMs) for heavy menstrual bleeding (HMB) remains limited. This trial evaluated their efficacy and safety against placebo. A single-center, randomized (2:1), double-blind, placebo-controlled, parallel-group trial was conducted in Kolkata, India, with 66 reproductive-age females with HMB (baseline pictorial blood loss assessment chart [PBAC] 100–185). Outcomes were assessed every cycle until 6 cycles (∼6 months). The primary efficacy estimand was the group difference in PBAC score at six months; secondary estimands included the group differences in the Menstrual Bleeding Questionnaire (MBQ) and Measure Yourself Medical Outcome Profile, version 2 (MYMOP2) at six months. The intention-to-treat sample (n = 66) was analyzed using baseline-adjusted and Bonferroni multiplicity-corrected Welch t-tests or Brunner-Munzel tests and several exploratory longitudinal, causality, evidence resilience, sensitivity, and subgroup/moderator analyses. At six months, median PBAC scores were 110.0 (IQR 95.5–123.0) in the IHMs group and 123.5 (IQR 117.5–137.0) in the placebo group; the difference remained statistically significant after Bonferroni correction (p adj. = 0.011; stochastic superiority 0.749, 95% CI 0.62–0.88). MYMOP2 scores also favored IHMs (p adj. = 0.001), but not the MBQ. Longitudinal models revealed significant group × time interactions. Causality frameworks indicated heterogeneous sample-wide benefit. Evidence resilience indicated robustness to unmeasured confounding. Sensitivity analyses confirmed consistency. Four mild adverse events were reported; all resolved completely, with no serious adverse events. IHMs improved PBAC and MYMOP2 scores over six months, but not MBQ; these preliminary findings require confirmation in larger multicenter trials. Trial registration: CTRI/2024/12/078220.

Files

Institutions

Categories

Menstrual Cycle, Randomized Clinical Trial, Menstrual Cycle Pain, Menstrual Bleeding Patterns

Licence